Merck & Co., Inc.
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30250% above fair value
$149.52+3.19 (+2.18%)
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Income from Discontinued Operations, Net of Taxes by Year
Income from Discontinued Operations, Net of Taxes (Organon Spin-Off) ($M) ($M)
Merck Income from Discontinued Operations, Net of Taxes: $0M in FY2023. No newer figure appears in the documents we track.
Latest, FY2023
0
Period ended Dec 31, 2023
Change on a year earlier
–
0 in FY2022
History
5 years
Since FY2019
Sources
3
Documents cited below
Where the FY2023 figure comes from
Source: Form 10-K (filed 2024-02-26) ↗
Reported in Postgres DB financial_values.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Income from Discontinued Operations, Net of Taxes (Organon Spin-Off) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2023 | Dec 31, 2023 | 0 | – | Form 10-K (filed 2024-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 0 | -100.0% | Form 10-K (filed 2023-02-24) ↗ |
| FY2021 | Dec 31, 2021 | 707 | -72.4% | Form 10-K (filed 2022-02-25) ↗ |
| FY2020 | Dec 31, 2020 | 2,559 | -38.6% | Form 10-K (filed 2022-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 4,171 | – | Form 10-K (filed 2022-02-25) ↗ |
Cite this data
StockData. (2026). Merck Income from Discontinued Operations, Net of Taxes ($M), annual FY2019–FY2023 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db-inc-disc-ogn
See every metric in the Merck KPI table. Data updated Oct 26, 2026.